Showing results (151-160 of 180) with videos related to
Sort By:
Pageof 18
British Journal of Cancer|December 13, 2006
Mortality within 30 days of chemotherapy: a clinical governance benchmarking issue for oncology patientsM E R O'Brien, A Borthwick, A Rigg, et al.Acta Endocrinologica|March 1, 1989
Two-monthly depot gonadotropin releasing hormone agonist (buserelin) for treatment of prostatic cancerJ H Waxman, J Sandow, P Abel, et al.Journal of Wrist Surgery|February 7, 2019
The Twist X-Ray: A Novel Test for Dynamic Scapholunate InstabilitySheena K Sikora, Stephen K Tham, Jason N Harvey, et al.British Journal of Urology|February 1, 1992
Bladder cancer: inter-relationships between chemotherapy and radiotherapyJ Waxman, C Barton, R Biruls, et al.American Journal of Physiology. Cell Physiology|January 15, 2016
Heat shock protein 70 regulates platelet integrin activation, granule secretion and aggregationRachel A Rigg, Laura D Healy, Marie S Nowak, et al.Platelets|May 20, 2017
Potentiation of TRAP-6-induced platelet dense granule release by blockade of P2Y12 signaling with MRS2395Annachiara Mitrugno, Rachel A Rigg, Nicole B Laschober, et al.Current Problems in Cancer|March 1, 1983
Gestational carcinoma of the female breastM K Wallack, J A Wolf, J Bedwinek, et al.Thrombosis Research|December 21, 2014
The BCR-ABL inhibitor ponatinib inhibits platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling, platelet activation and aggregate formation under shearCassandra P Loren, Joseph E Aslan, Rachel A Rigg, et al.Cellular and Molecular Bioengineering|May 21, 2019
Design and Utility of a Point-of-Care Microfluidic Platform to Assess Hematocrit and Blood CoagulationJevgenia Zilberman-Rudenko, Rachel M White, Dmitriy A Zilberman, et al.American Journal of Clinical Oncology|January 1, 1988
The clinical and endocrine assessment of three different antiandrogen regimens combined with a very long-acting gonadotrophin-releasing hormone analogueJ Waxman, G Williams, J Sandow, et al.Pageof 18